HK1159064A1 - Processes for the preparation of aminosulfone compounds - Google Patents

Processes for the preparation of aminosulfone compounds

Info

Publication number
HK1159064A1
HK1159064A1 HK11112896.7A HK11112896A HK1159064A1 HK 1159064 A1 HK1159064 A1 HK 1159064A1 HK 11112896 A HK11112896 A HK 11112896A HK 1159064 A1 HK1159064 A1 HK 1159064A1
Authority
HK
Hong Kong
Prior art keywords
processes
preparation
aminosulfone compounds
aminosulfone
compounds
Prior art date
Application number
HK11112896.7A
Other languages
English (en)
Inventor
Manohar T Saindane
Chuansheng Ge
Original Assignee
Celgene Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Celgene Corp filed Critical Celgene Corp
Publication of HK1159064A1 publication Critical patent/HK1159064A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C315/00Preparation of sulfones; Preparation of sulfoxides
    • C07C315/04Preparation of sulfones; Preparation of sulfoxides by reactions not involving the formation of sulfone or sulfoxide groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK11112896.7A 2008-09-10 2011-11-28 Processes for the preparation of aminosulfone compounds HK1159064A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9590208P 2008-09-10 2008-09-10
PCT/US2009/005055 WO2010030345A2 (en) 2008-09-10 2009-09-09 Processes for the preparation of aminosulfone compounds

Publications (1)

Publication Number Publication Date
HK1159064A1 true HK1159064A1 (en) 2012-07-27

Family

ID=41565187

Family Applications (1)

Application Number Title Priority Date Filing Date
HK11112896.7A HK1159064A1 (en) 2008-09-10 2011-11-28 Processes for the preparation of aminosulfone compounds

Country Status (16)

Country Link
US (1) US8242310B2 (xx)
EP (1) EP2334639B1 (xx)
JP (1) JP5513508B2 (xx)
CN (1) CN102209709B (xx)
CA (1) CA2736171A1 (xx)
DK (1) DK2334639T3 (xx)
ES (1) ES2404336T3 (xx)
HK (1) HK1159064A1 (xx)
HR (1) HRP20130356T1 (xx)
MX (1) MX2011002589A (xx)
MY (1) MY155424A (xx)
PL (1) PL2334639T3 (xx)
PT (1) PT2334639E (xx)
SI (1) SI2334639T1 (xx)
SM (1) SMT201300045B (xx)
WO (1) WO2010030345A2 (xx)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7893101B2 (en) 2002-03-20 2011-02-22 Celgene Corporation Solid forms comprising (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione, compositions thereof, and uses thereof
US9532977B2 (en) 2010-12-16 2017-01-03 Celgene Corporation Controlled release oral dosage forms of poorly soluble drugs and uses thereof
CN103442698B (zh) 2010-12-16 2016-10-05 细胞基因公司 难溶性药物的控释口服剂量形式及其用途
WO2012097116A2 (en) 2011-01-14 2012-07-19 Celgene Corporation Isotopologues of isoindole derivatives
KR101889757B1 (ko) 2011-04-28 2018-08-20 셀진 코포레이션 자가 면역 및 염증 질환의 치료 및 관리를 위한 pde4 저해제를 이용한 방법 및 조성물
EP2765993B1 (en) 2011-09-14 2020-05-20 Amgen (Europe) GmbH Formulations of cyclopropanecarboxylic acid {2-[(1s)-1-(3-ethoxy-4-methoxy-phenyl)-2-methanesulfonyl-ethyl]-3-oxo-2, 3-dihydro-1h-isoindol-4-yl}-amide
US9126906B2 (en) 2012-02-21 2015-09-08 Celgene Corporation Asymmetric synthetic processes for the preparation of aminosulfone compounds
AR090100A1 (es) 2012-02-21 2014-10-22 Celgene Corp Procesos para la preparacion de la (s)-1-(3-etoxi-4-metoxifenil)-2-metanosulfoniletilamina
EP2764866A1 (en) 2013-02-07 2014-08-13 IP Gesellschaft für Management mbH Inhibitors of nedd8-activating enzyme
BR112015020584A2 (pt) 2013-03-14 2017-07-18 Celgene Corp métodos para o tratamento de artrite psoriática usando apremilast
US9468605B2 (en) 2013-06-17 2016-10-18 Celgene Corporation Formulations of (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione
ES2751773T3 (es) 2014-05-15 2020-04-01 Amgen Europe Gmbh Uso de inhibidores pde4 y combinaciones de los mismos para el tratamiento de la fibrosis quística
US20170087129A1 (en) 2014-05-16 2017-03-30 Celgene Corporation Compositions and methods for the treatment of atherosclerotic cardiovascular diseases with pde4 modulators
EP2949645A1 (en) 2014-05-28 2015-12-02 LEK Pharmaceuticals d.d. Processes for the preparation of ß-aminosulfone compounds
JP6687550B2 (ja) 2014-06-23 2020-04-22 セルジーン コーポレイション 肝疾患又は肝機能異常を治療するためのアプレミラスト
EP3188745A1 (en) 2014-08-15 2017-07-12 Celgene Corporation Dosage titration of apremilast for the treatment of diseases ameliorated by pde4 inhibition
BR112017025262A2 (pt) 2015-05-26 2018-07-31 Lupin Ltd processo aperfeiçoado para preparação de apremilast e seus novos polimorfos
BR112017026560A2 (pt) * 2015-06-09 2018-08-14 Dr Reddys Laboratories Ltd processo para preparação de apremilast e seus intermediários.
EP3106457A1 (en) 2015-06-15 2016-12-21 LEK Pharmaceuticals d.d. A novel synthetic pathway towards apremilast
EP3144393A1 (en) 2015-09-18 2017-03-22 LEK Pharmaceuticals d.d. A synthetic pathway towards apremilast
EP3356327A1 (en) 2015-09-29 2018-08-08 Pliva Hrvatska D.O.O. Processes for the preparation of apremilast and intermediates thereof
US10682336B2 (en) 2015-10-21 2020-06-16 Amgen Inc. PDE4 modulators for treating and preventing immune reconstitution inflammatory syndrome (IRIS)
WO2017083348A1 (en) 2015-11-11 2017-05-18 Celgene Corporation Controlled release oral dosage forms of poorly soluble drugs and uses thereof
WO2017179065A1 (en) 2016-04-15 2017-10-19 Davuluri Ramamohan Rao Improved process for the preparation of apremilast
CN106543050B (zh) * 2016-09-28 2018-04-10 中南大学湘雅医院 一种阿普斯特中间体的合成工艺
US10689332B2 (en) 2017-04-04 2020-06-23 Quimica Sintetica, S.A. Racemic beta-aminosulfone compounds
HUE051684T2 (hu) 2017-04-04 2021-03-29 Quim Sintetica S A Racém béta-aminoszulfon vegyületek rezolválása
CN107011209A (zh) * 2017-05-11 2017-08-04 蚌埠中实化学技术有限公司 一种3‑甲氧基‑4‑乙氧基苯腈的合成新工艺
CN115572248B (zh) * 2022-11-08 2024-04-26 中山大学 一种制备β-氨基砜类化合物的方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8501192D0 (en) * 1985-01-17 1985-02-20 Boots Co Plc Therapeutic agents
JPH02289584A (ja) * 1989-02-17 1990-11-29 Takeda Chem Ind Ltd セファロスポリンγ―ラクトン化合物
EP0731086B1 (de) * 1995-03-09 1999-04-28 Ciba SC Holding AG Verfahren zur Herstellung aromatischer Nitrile
JPH1087547A (ja) * 1996-09-13 1998-04-07 Nippon Soda Co Ltd 光学活性合成中間体の製造法
GB9711650D0 (en) * 1997-06-05 1997-07-30 Pfizer Ltd Compounds useful in therapy
US6020358A (en) * 1998-10-30 2000-02-01 Celgene Corporation Substituted phenethylsulfones and method of reducing TNFα levels
JP5269281B2 (ja) * 2002-12-30 2013-08-21 セルジーン コーポレイション フルオロアルコキシ置換1,3−ジヒドロイソインドリル化合物およびそれらの医薬としての使用

Also Published As

Publication number Publication date
DK2334639T3 (da) 2013-05-06
CA2736171A1 (en) 2010-03-18
WO2010030345A2 (en) 2010-03-18
EP2334639A2 (en) 2011-06-22
EP2334639B1 (en) 2013-01-23
PL2334639T3 (pl) 2013-08-30
ES2404336T3 (es) 2013-05-27
CN102209709B (zh) 2014-08-13
JP2012502097A (ja) 2012-01-26
PT2334639E (pt) 2013-04-26
MY155424A (en) 2015-10-15
CN102209709A (zh) 2011-10-05
SMT201300045B (it) 2013-07-09
US8242310B2 (en) 2012-08-14
SI2334639T1 (sl) 2013-06-28
MX2011002589A (es) 2011-04-07
HRP20130356T1 (xx) 2013-05-31
JP5513508B2 (ja) 2014-06-04
WO2010030345A3 (en) 2010-05-06
US20100168475A1 (en) 2010-07-01

Similar Documents

Publication Publication Date Title
HK1159064A1 (en) Processes for the preparation of aminosulfone compounds
MX2010003599A (es) Intermediarios y metodos para la sintesis de analogos de halicondrina b.
WO2013126495A3 (en) Asymmetric synthetic processes for the preparation of aminosulfone compounds
HRP20130800T1 (xx) Modulatori opioidnog receptora
HK1148213A1 (en) Process for producing powdery cosmetic preparation
MX2010007605A (es) Pirrolo-pirimidas y pirrolo-piridinas.
CL2011000936A1 (es) Proceso de preparacion de compuestos derivados de l-alanina protegidos, utiles como intermediarios de la sintesis de compuestos moduladores opioides mu/delta.
MX2011009369A (es) 2-mercaptoquinolin-3-carboxamidas sustituidas como moduladores de kcnq2/3.
MX2010005530A (es) Activadores de receptor de vitamina d nuevos y metodos de elaboracion de los mismos.
EP2379493A4 (en) PROCESS FOR THE PREPARATION OF ASYMMETRIC BIS (THIOSEMICARBAZONES)
ZA201008222B (en) Process for the synthesis of arformoterol
MX2011008825A (es) 3-aminoisoxazolopiridinas sustituidas como moduladores de kcnq2/3.
WO2010068282A3 (en) Compositions and methods for synthesis of hydrogen fuel
WO2009005647A3 (en) Compounds and process to prepare chiral intermediates for synthesis of paroxetine
TW200728310A (en) Process for the preparation of ferri-succinylcasein
ZA200705216B (en) Novel process for the preparation of substituted indoles
HK1155436A1 (en) Process for the preparation of naphthalen-2-yl-pyrazol-3-one intermediates useful in the synthesis of sigma receptor inhibitors -2---3-
MX2010004546A (es) Nuevos intermedios de pregabalina y procedimiento para prepararlos y para preparar pregabalina.
PL412210A1 (pl) Silnie fluorescencyjne substancje heterocykliczne i sposób ich syntezy
MX2011008662A (es) 2-mercapto-3-aminopiridinas sustituidas como moduladores de kcnq2/3.
MX2011009338A (es) 3-amino-2-mercaptoquinolinas sustituidas como moduladores de kcnq2/3.
HK1124842A1 (en) Methods of preparing imidazole-based compounds
MX2010005809A (es) Proceso de dehidrohalogenacion para la preparacion de intermediarios utiles en el suministro de compuestos 6,6-dimetil-3-azabiciclo-[3,1,0]-hexano.
TW200738713A (en) Diazepinoquinolines, synthesis thereof, and intermediates thereto
MX2012006524A (es) Proceso para la sintesis de compuestos intermedios de utilidad para preparar compuestos sustituidos de indazol y azaindol.

Legal Events

Date Code Title Description
PS Patent surrendered
PS Patent surrendered